| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiomyopathy, Hypertrophic | |||||
| Heart Hypertrophy | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Cardiomegaly | |||||
| Cardiomyopathies | |||||
| Hypertrophy | |||||
| Hypertrophy, Left Ventricular | |||||
| 3 | More general conditions related to this trial | ||||
| Aortic Stenosis, Subvalvular | |||||
| Aortic Valve Stenosis | |||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Heart Valve Diseases | |||||
| Pathological Conditions, Anatomical | |||||
| 4 | Interventions listed in this trial | ||||
| Cyclosporine A | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Cyclosporine | |||||
| Cyclosporins | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Antifungal Agents | |||||
| Antirheumatic Agents | |||||
| Dermatologic Agents | |||||
| Enzyme Inhibitors | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||
|
